(Q39720943)
Statements
1 reference
Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity (English)
M. Ali
1 December 1979
1 reference
1 reference
3
1 reference
6
1 reference
327-332
1 reference
8
301
Controlled trial of aspirin in cerebral ischemia (English)
Fields
1977
299
53
A randomized trial of aspirin and sulfinpyrazone. I. Methods and neurologic results (English)
1978
297
1246
Aspirin prophylaxis of venous thromboembolism after total hip replacement (English)
Harris
1977
298
289
Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial (English)
1978
1
894
Effect of anti-inflammatory agents on platelets (English)
O'Brien
0 references
231
235
Aspirin selectively inhibits prostaglandin production in human platelets (English)
Smith
1971
11
23
Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins (English)
Rome
1976
11
485
Synthesis of prostaglandin D2 and thromboxane B2 by human platelets (English)
1977
13
1057
Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antiinflammatory drugs (English)
1978
56
713
Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies (English)
Harris
1967
47
2169
The effect of salicylates on the hemostatic properties of platelets in man (English)
Weiss
1968
50
231
The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines (English)
Vargaftig
1978
63
35
Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid (English)
Lefort
1978
12
247
Determination of sulfinpyrazone in patient plasma by gas chromatography (English)
Rosenfeld
1978
1 reference
Identifiers
1 reference
1 reference